Argus 2.0 Adoption Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.
Also called NCT07425236
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose device feasibility
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- KOS Inc.
- Registry
-
NCT07425236
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07425236. Non-randomized; no masking; primary purpose device feasibility. Start 2026-04-19 (anticipated); primary completion 2026-08-19 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Argus 2.0 Adoption Study
- Condition
- Diabetes
- Condition
- Diabetes Mellitus, Type 1 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Prediabetes
- Intervention (Device)
- KOS Argus Continuous Glucose Monitoring System
- Lead sponsor
- KOS Inc.
Record details
- Record id
cardio:ct-nct07425236- Content hash
19f1f0fb47b43b1ba568913d8b6de1caf3e959443748d24e30914cdeb66f4e90